24 UQ researchers have been awarded more than $46 million in research funding through the National Health and Medical Research Council (NHMRC) Investigator Grants and Partnership Projects schemes.
28 February 2025
The University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved vaccine considered among the best in its class.
23 November 2023
Recruitment is underway for a pivotal proof-of-concept human trial of The University of Queensland’s second-generation molecular clamp vaccine.
20 March 2023
A University of Queensland team has become the biggest supplier of experimental mRNA vaccines and therapies in Australia, with burgeoning demand from research and industry across the country.
11 January 2023
Queensland will become a global mRNA vaccine hub with a $280 million Translational Science Hub to be established in Queensland.
5 December 2022
The University of Queensland is set to take a second-generation molecular clamp vaccine to a proof-of-concept human trial.
25 November 2022
The University of Queensland has recognised the outstanding contribution to society of medical researcher and philanthropist Ian Frazer AC by renaming the UQ Diamantina Institute in his honour.
11 November 2022
Researchers at The University of Queensland have been awarded international funding to combat an expected escalation of skin cancer cases in US troops who served in Iraq and Afghanistan.
12 September 2022
The incidence of alcohol-related violence fell in Queensland’s key nightlife areas while business continued to grow after the Queensland Government’s Tackling Alcohol Fuelled Violence (TAFV) policy was introduced, independent research has found.
21 May 2021
University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective.
20 April 2021
The Australian government is urgently deploying 8,000 vaccine doses to Papua New Guinea's health workers – but poor electricity access means there are serious questions over PNG’s broader vaccine roll-out.
19 March 2021
New treatments to cut the global death rate from dengue, Zika and West Nile viruses could result from research led by The University of Queensland.
8 January 2021
Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile.
11 December 2020
Global biotech company CSL Limited will supply the Australian Government with 51 million doses of The University of Queensland’s COVID-19 vaccine candidate if it proves successful, under a heads of agreement announced today.
7 September 2020
A call to arms has gone out to Queenslanders aged 56 and over to help advance The University of Queensland’s COVID-19 vaccine project.
27 August 2020
A landmark partnership will help to accelerate the future development, manufacture and distribution of a University of Queensland COVID-19 vaccine.
5 June 2020
Developing early and improved diagnostic tests to lift ovarian cancer survival rates are the focus of two research projects commencing at The University of Queensland.
25 May 2020
A funding injection of up to $17 million for vital University of Queensland research could help cut the timeline for an effective vaccine for COVID-19 by six months.
22 March 2020
A comprehensive tool to help people manage back pain has been developed by a team of international health experts led by University of Queensland researchers.
30 July 2019
Vaccines to stop the world’s next epidemic could be developed in record time under a $14.7 million partnership using technology developed at The University of Queensland.
16 January 2019- 1 of 3
- next ›
